Literature DB >> 15917293

Stat3 is required for full neoplastic transformation by the Simian Virus 40 large tumor antigen.

Adina Vultur1, Rozanne Arulanandam, James Turkson, Guilian Niu, Richard Jove, Leda Raptis.   

Abstract

To investigate the role of Stat3 (signal transducer and activator of transcription-3) in neoplastic transformation by the Large Tumor antigen of Simian Virus 40 (TAg), murine fibroblasts were rendered deficient in Stat3 activity through expression of a Stat3-specific siRNA or a Cre-loxP recombination system. The results demonstrate that growth rate, formation of foci overgrowing a monolayer of normal cells and colony formation in soft agar were dramatically reduced in Stat3-deficient cells. In addition, TAg expression led to increased Stat3 tyrosine phosphorylation, DNA binding, and transcriptional activity, suggesting that Stat3 is required for TAg-mediated neoplasia. Stat3 activation was prevented by blocking the binding of TAg to pRb (retinoblastoma-susceptibility gene product), whereas genetic ablation of pRb increased Stat3 activity, suggesting that pRb inactivation by TAg might be responsible for the observed Stat3 activation. Stat3 activation by TAg was suppressed after inhibition of c-Src, JAKs or the insulin-like growth factor receptor. On the other hand, targeted disruption of the Fer kinase or pharmacological inhibition of Abl had no effect. Inhibition of Src activity led to Stat3 down-regulation as well as apoptosis of sparsely growing, TAg-transformed cells. However, Src inhibition was relatively ineffective in confluent cells, consistent with previous results indicating that cell to cell adhesion activates Stat3 by a Src-independent mechanism. Direct Stat3 inhibition on the other hand induced apoptosis very effectively in confluent cells, which could have significant therapeutic implications. Taken together, our results suggest that Stat3 is an important component of a pathway emanating from TAg and leading to neoplastic conversion.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15917293      PMCID: PMC1182320          DOI: 10.1091/mbc.e04-12-1104

Source DB:  PubMed          Journal:  Mol Biol Cell        ISSN: 1059-1524            Impact factor:   4.138


  61 in total

1.  Targeted disruption of the three Rb-related genes leads to loss of G(1) control and immortalization.

Authors:  J Sage; G J Mulligan; L D Attardi; A Miller; S Chen; B Williams; E Theodorou; T Jacks
Journal:  Genes Dev       Date:  2000-12-01       Impact factor: 11.361

2.  Transfection techniques affecting Stat3 activity levels.

Authors:  R Arulanandam; A Vultur; L Raptis
Journal:  Anal Biochem       Date:  2005-03-01       Impact factor: 3.365

3.  Activation of Stat3 in v-Src-transformed fibroblasts requires cooperation of Jak1 kinase activity.

Authors:  Y Zhang; J Turkson; C Carter-Su; T Smithgall; A Levitzki; A Kraker; J J Krolewski; P Medveczky; R Jove
Journal:  J Biol Chem       Date:  2000-08-11       Impact factor: 5.157

Review 4.  Roles of STAT3 defined by tissue-specific gene targeting.

Authors:  S Akira
Journal:  Oncogene       Date:  2000-05-15       Impact factor: 9.867

5.  Constitutive activation of Stat3 by the Src and JAK tyrosine kinases participates in growth regulation of human breast carcinoma cells.

Authors:  R Garcia; T L Bowman; G Niu; H Yu; S Minton; C A Muro-Cacho; C E Cox; R Falcone; R Fairclough; S Parsons; A Laudano; A Gazit; A Levitzki; A Kraker; R Jove
Journal:  Oncogene       Date:  2001-05-03       Impact factor: 9.867

6.  Activation of Stat3 preassembled with platelet-derived growth factor beta receptors requires Src kinase activity.

Authors:  Y Z Wang; W Wharton; R Garcia; A Kraker; R Jove; W J Pledger
Journal:  Oncogene       Date:  2000-04-20       Impact factor: 9.867

7.  Specific inhibition of growth factor-stimulated extracellular signal-regulated kinase 1 and 2 activation in intact cells by electroporation of a growth factor receptor-binding protein 2-Src homology 2 binding peptide.

Authors:  L Raptis; H L Brownell; A M Vultur; G M Ross; E Tremblay; B E Elliott
Journal:  Cell Growth Differ       Date:  2000-06

8.  Tissue-specific autoregulation of the stat3 gene and its role in interleukin-6-induced survival signals in T cells.

Authors:  M Narimatsu; H Maeda; S Itoh; T Atsumi; T Ohtani; K Nishida; M Itoh; D Kamimura; S J Park; K Mizuno; J Miyazaki; M Hibi; K Ishihara; K Nakajima; T Hirano
Journal:  Mol Cell Biol       Date:  2001-10       Impact factor: 4.272

9.  Simian virus 40 large tumor antigen modulates the Raf signaling pathway.

Authors:  N Grammatikakis; K Jaronczyk; A Siganou; A Vultur; H L Brownell; M Benzaquen; C Rausch; R Lapointe; O Gjoerup; T M Roberts; L Raptis
Journal:  J Biol Chem       Date:  2001-05-29       Impact factor: 5.157

10.  Inhibition of STAT3 signaling leads to apoptosis of leukemic large granular lymphocytes and decreased Mcl-1 expression.

Authors:  P K Epling-Burnette; J H Liu; R Catlett-Falcone; J Turkson; M Oshiro; R Kothapalli; Y Li; J M Wang; H F Yang-Yen; J Karras; R Jove; T P Loughran
Journal:  J Clin Invest       Date:  2001-02       Impact factor: 14.808

View more
  21 in total

1.  Gambogic acid inhibits STAT3 phosphorylation through activation of protein tyrosine phosphatase SHP-1: potential role in proliferation and apoptosis.

Authors:  Sahdeo Prasad; Manoj K Pandey; Vivek R Yadav; Bharat B Aggarwal
Journal:  Cancer Prev Res (Phila)       Date:  2011-04-13

Review 2.  The R(h)oads to Stat3: Stat3 activation by the Rho GTPases.

Authors:  Leda Raptis; Rozanne Arulanandam; Mulu Geletu; James Turkson
Journal:  Exp Cell Res       Date:  2011-05-18       Impact factor: 3.905

3.  Effect of caveolin-1 on Stat3-ptyr705 levels in breast and lung carcinoma cells.

Authors:  Mulu Geletu; Zaid Taha; Rozanne Arulanandam; Reva Mohan; Hikmat H Assi; Maria G Castro; Ivan Robert Nabi; Patrick T Gunning; Leda Raptis
Journal:  Biochem Cell Biol       Date:  2019-04-15       Impact factor: 3.626

4.  A functional assay for gap junctional examination; electroporation of adherent cells on indium-tin oxide.

Authors:  Mulu Geletu; Stephanie Guy; Kevin Firth; Leda Raptis
Journal:  J Vis Exp       Date:  2014-10-18       Impact factor: 1.355

5.  Crif1 is a novel transcriptional coactivator of STAT3.

Authors:  Min-chul Kwon; Bon-Kyoung Koo; Jin-Sook Moon; Yoon-Young Kim; Ki Cheol Park; Nam-Shik Kim; Mi Yi Kwon; Myung-Phil Kong; Ki-Jun Yoon; Sun-Kyoung Im; Jaewang Ghim; Yong-Mahn Han; Sung Key Jang; Minho Shong; Young-Yun Kong
Journal:  EMBO J       Date:  2008-01-17       Impact factor: 11.598

6.  Targeted Blockade of JAK/STAT3 Signaling Inhibits Ovarian Carcinoma Growth.

Authors:  Galina Gritsina; Fang Xiao; Shane W O'Brien; Rashid Gabbasov; Marisa A Maglaty; Ren-Huan Xu; Roshan J Thapa; Yan Zhou; Emmanuelle Nicolas; Samuel Litwin; Siddharth Balachandran; Luis J Sigal; Dennis Huszar; Denise C Connolly
Journal:  Mol Cancer Ther       Date:  2015-02-02       Impact factor: 6.261

7.  SKI-606 (bosutinib), a novel Src kinase inhibitor, suppresses migration and invasion of human breast cancer cells.

Authors:  Adina Vultur; Ralf Buettner; Claudia Kowolik; Wei Liang; David Smith; Frank Boschelli; Richard Jove
Journal:  Mol Cancer Ther       Date:  2008-05       Impact factor: 6.261

Review 8.  Engaged for survival: From cadherin ligation to STAT3 activation.

Authors:  Mulu Geletu; Stephanie Guy; Rozanne Arulanandam; Hélène Feracci; Leda Raptis
Journal:  JAKSTAT       Date:  2013-12-06

9.  Aberrant expression and constitutive activation of STAT3 in cervical carcinogenesis: implications in high-risk human papillomavirus infection.

Authors:  Shirish Shukla; Gauri Shishodia; Sutapa Mahata; Suresh Hedau; Arvind Pandey; Suresh Bhambhani; Swaraj Batra; Seemi F Basir; Bhudev C Das; Alok C Bharti
Journal:  Mol Cancer       Date:  2010-10-27       Impact factor: 27.401

10.  Stat3 is a positive regulator of gap junctional intercellular communication in cultured, human lung carcinoma cells.

Authors:  Mulu Geletu; Rozanne Arulanandam; Samantha Greer; Aaron Trotman-Grant; Evangelia Tomai; Leda Raptis
Journal:  BMC Cancer       Date:  2012-12-18       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.